As the blockade of CSF-1R has been shown to deplete TAMs [26], or to repolarize them to an M1 anti-tumor phenotype [23,24,25], we next assessed the effects of anti-CSF-1R on TAMs in tumors with reduced MHC-I expression by flow cytometry. Here, CSF1R is linked to neoplasm.